-
Some pharmacy staff from Walgreens, other chains are walking out again — here's what you need to know
The walkouts are the latest pushback against what pharmacy staff claim are harsh and unsafe working conditions that put both employees and patients at risk.
-
As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge
For now, Eli Lilly’s orforglipron appears to be the top contender in the weight loss pill space due to its strong efficacy data and ease of use.
-
Ruling Clears Way for Purdue Pharma to Settle Opioid Claims, Protect Sacklers From Lawsuits
A federal court cleared the way for the Sackler family, owners of Purdue Pharma, to settle thousands of claims over the toll of opiods, seemingly without the threat of civil lawsuits.
-
Powerful New Obesity Drug Poised to Upend Weight Loss Care
A diabetes drug being tested for weight loss is poised to further upend obesity care.
-
Eli Lilly Says Experimental Alzheimer's Drug Reduces Brain Plaque in Early Study
Eli Lilly said a higher dose of the up-and-coming Alzheimer’s treatment remternetug had a larger effect on clearing amyloid plaque.
-
Johnson & Johnson to Pay $8.9 Billion to Settle Talc Cancer Claims
Johnson & Johnson said it would pay an $8.9 billion settlement over claims that its talc-based baby powder caused cancer.